In a letter on Thursday, New York Attorney General Letitia James called on the FDA to “take immediate action” and renew alerts to doctors and patients about the dangerous effects of Singulair for children, saying that the current warnings about the drug’s psychiatric side effects are not sufficient. James also called on the FDA to consider discouraging the prescription of Singulair to children. The FDA in 2020 warned that Merck’s Singulair could cause aggression, agitation and even suicidal thoughts, but many people weren’t informed, and the drug was still prescribed to 12M people in the U.S. as of 2022, The New York Times reported last month.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MRK:
- Evaxion announces completion of initial phases of collaboration with MSD
- Merck: FDA grants priority review to sBLA for Keytruda plus chemotherapy
- Merus price target raised to $56 from $48 at Guggenheim
- Soros buys Birkenstock and Merck, exits LPL Financial and General Motors
- Cantor biotech/biopharma analysts to hold analyst/industry conference call
